Greg Matlashewski

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Dendritic Cells

Immune Response

Top Venues

Nature communications

PLoS neglected tropical diseases

Journal of clinical microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Ranadhir Dey, Jalal Alshaweesh, Kamaleshwar P Singh, Patrick Lypaczewski, Subir Karmakar, Laura Klenow, Kayla Paulini, Swarnendu Kaviraj, Shaden Kamhawi, Jesus G Valenzuela, Sanjay Singh, Shinjiro Hamano, Abhay R Satoskar, Sreenivas Gannavaram, Hira L Nakhasi, Greg Matlashewski
Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field. Nature communications 14 (1) (2023)
Subir Karmakar, Greta Volpedo, Wen Wei Zhang, Patrick Lypaczewski, Nevien Ismail, Fabiano Oliveira, James Oristian, Claudio Meneses, Sreenivas Gannavaram, Shaden Kamhawi, Shinjiro Hamano, Jesus G Valenzuela, Greg Matlashewski, Abhay R Satoskar, Ranadhir Dey, Hira L Nakhasi
Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis. NPJ vaccines 7 (1) (2022)
Wen Wei Zhang, Douglas G Wright, Lynn Harrison, Greg Matlashewski
Reconstitution of Mycobacterium marinum Nonhomologous DNA End Joining Pathway in Leishmania . mSphere 7 (3) (2022)
Subir Karmakar, Nevien Ismail, Fabiano Oliveira, James Oristian, Wen Wei Zhang, Swarnendu Kaviraj, Kamaleshwar P Singh, Abhishek Mondal, Sushmita Das, Krishna Pandey, Parna Bhattacharya, Greta Volpedo, Sreenivas Gannavaram, Monika Satoskar, Sanika Satoskar, Rajiv M Sastry, Timur Oljuskin, Telly Sepahpour, Claudio Meneses, Shinjiro Hamano, Pradeep Das, Greg Matlashewski, Sanjay Singh, Shaden Kamhawi, Ranadhir Dey, Jesus G Valenzuela, Abhay Satoskar, Hira L Nakhasi
Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis. Communications biology 4 (1) (2021)
Helen Ashwin, Jovana Sadlova, Barbora Vojtkova, Tomas Becvar, Patrick Lypaczewski, Eli Schwartz, Elizabeth Greensted, Katrien Van Bocxlaer, Marion Pasin, Kai S Lipinski, Vivak Parkash, Greg Matlashewski, Alison M Layton, Charles J Lacey, Charles L Jaffe, Petr Volf, Paul M Kaye
Characterization of a new Leishmania major strain for use in a controlled human infection model. Nature communications 12 (1) (2021)
Cedric P Yansouni, Jesse Papenburg, Matthew P Cheng, Rachel Corsini, Chelsea Caya, Fabio Vasquez Camargo, Luke B Harrison, Gerasimos Zaharatos, Philippe Büscher, Babacar Faye, Magatte Ndiaye, Greg Matlashewski, Momar Ndao
Specificity of SARS-CoV-2 antibody-detection assays against S and N protein among pre-COVID-19 sera from patients with protozoan and helminth parasitic infections. Journal of clinical microbiology (2021)
Jessica Carstens-Kass, Kayla Paulini, Patrick Lypaczewski, Greg Matlashewski
A review of the leishmanin skin test: A neglected test for a neglected disease. PLoS neglected tropical diseases 15 (7) (2021)
Patrick Lypaczewski, Wen-Wei Zhang, Greg Matlashewski
Evidence that a naturally occurring single nucleotide polymorphism in the RagC gene of Leishmania donovani contributes to reduced virulence. PLoS neglected tropical diseases 15 (2) (2021)
Adele Goldman-Pinkovich, Sriram Kannan, Roni Nitzan-Koren, Madhu Puri, Harsh Pawar, Yael Bar-Avraham, Jacquelyn McDonald, Aakash Sur, Wen-Wei Zhang, Greg Matlashewski, Rentala Madhubala, Shulamit Michaeli, Peter J Myler, Dan Zilberstein
Sensing Host Arginine Is Essential for Leishmania Parasites' Intracellular Development. mBio 11 (5) (2020)
Wen Wei Zhang, Subir Karmakar, Sreenivas Gannavaram, Ranadhir Dey, Patrick Lypaczewski, Nevien Ismail, Abid Siddiqui, Vahan Simonyan, Fabiano Oliveira, Iliano V Coutinho-Abreu, Thiago DeSouza-Vieira, Claudio Meneses, James Oristian, Tiago D Serafim, Md Abu Musa, Risa Nakamura, Noushin Saljoughian, Greta Volpedo, Monika Satoskar, Sanika Satoskar, Pradeep K Dagur, J Philip McCoy, Shaden Kamhawi, Jesus G Valenzuela, Shinjiro Hamano, Abhay R Satoskar, Greg Matlashewski, Hira L Nakhasi
A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nature communications 11 (1) (2020)